Xtl Biopharma ADR (XTLB)

$0.83 -0.05 (-5.15%)
Market Cap 7.71M
Revenue (ttm) 450,000.00
Net Income (ttm) -1.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -228.89%
Debt to Equity Ratio -1.80
Volume 61,400
Avg Vol 870,114
Day's Range N/A - N/A
Shares Out 8.81M
Stochastic %K 26%
Beta 1.18
Analysts Strong Buy
Price Target $6.00

Company Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. Its lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. The company has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The com...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 611 6600
Address:
26 Ben-Gurion St., Ramat Gan, Israel
LindaRice1041
LindaRice1041 Feb. 21 at 9:06 AM
$XTLB Xtrackers Long/Short Carbon ETF uses emissions strategy. Performance depends on carbon pricing. Volatility is elevated.
0 · Reply
anonAlb
anonAlb Feb. 18 at 3:41 PM
$SUGP we blowing up here soon! Load load load 🚨🚨🚨🚀🚀🚀🚀🚀 $XTLB $SENS
0 · Reply
batmantradingzz
batmantradingzz Feb. 18 at 3:37 PM
$SUGP if u missed $SNSE $XTLB SUGP be early Potential next 500k floater to go
0 · Reply
CandleVoyager
CandleVoyager Feb. 18 at 10:00 AM
$XTLB Energy infrastructure exposure where contract stability underpins valuation.
0 · Reply
Maggie_Pie
Maggie_Pie Feb. 17 at 11:52 PM
$XTLB I'm in for these cheapies. GL very
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 5:18 PM
$XTLB RSI: 47.69, MACD: 0.0089 Vol: 0.09, MA20: 0.93, MA50: 0.85 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_EmproX
_EmproX Feb. 17 at 2:26 PM
$XTLB $LSE $FGNX $ENLT ****
0 · Reply
Kesiya
Kesiya Feb. 17 at 1:59 PM
$XTLB Buying zone.
1 · Reply
StonkTamer
StonkTamer Feb. 17 at 9:14 AM
$XTLB Obscure micro-cap; minimal coverage
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:13 PM
$XTLB RSI: 67.02, MACD: 0.0574 Vol: 0.18, MA20: 0.81, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on XTLB
XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Beyond Air (XAIR)

2026-01-29T22:31:47.000Z - 25 days ago

XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Beyond Air (XAIR)

XTL Update on Recent Developments

Thu, 29 Jan 2026 16:05:00 -0500 - 25 days ago

XTL Update on Recent Developments

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Fri, 23 Jan 2026 16:10:00 -0500 - 4 weeks ago

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Tue, 13 Jan 2026 09:28:00 -0500 - 5 weeks ago

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Biopharmaceuticals To Acquire 85% Stake In NeuroNOS Ltd For $32.5 Mln

2026-01-13T13:11:13.000Z - 5 weeks ago

XTL Biopharmaceuticals To Acquire 85% Stake In NeuroNOS Ltd For $32.5 Mln

Beyond Air (XAIR) Moves NeuroNOS to XTL Biopharmaceuticals Through Acquisition Deal

2026-01-13T12:53:54.000Z - 5 weeks ago

Beyond Air (XAIR) Moves NeuroNOS to XTL Biopharmaceuticals Through Acquisition Deal

XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice

2025-12-24T21:33:19.000Z - 2 months ago

XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Wed, 24 Dec 2025 16:00:00 -0500 - 2 months ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

XTL Names Mr. Noam Band as its New Chief Executive Officer

Mon, 07 Apr 2025 09:15:00 -0400 - 11 months ago

XTL Names Mr. Noam Band as its New Chief Executive Officer

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

Wed, 14 Aug 2024 09:15:00 -0400 - 1 year ago

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

XTL Entered Definitive Agreement to Acquire The Social Proxy

Wed, 05 Jun 2024 09:15:00 -0400 - 1 year ago

XTL Entered Definitive Agreement to Acquire The Social Proxy

XTL To Aquire The Social Proxy

Wed, 20 Mar 2024 10:15:00 -0400 - 2 years ago

XTL To Aquire The Social Proxy

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

Fri, 20 Oct 2023 16:00:00 -0400 - 2 years ago

XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Fri, 20 Oct 2023 16:00:00 -0400 - 2 years ago

XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting

Mon, 20 Sep 2021 09:05:00 -0400 - 4 years ago

Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting

LindaRice1041
LindaRice1041 Feb. 21 at 9:06 AM
$XTLB Xtrackers Long/Short Carbon ETF uses emissions strategy. Performance depends on carbon pricing. Volatility is elevated.
0 · Reply
anonAlb
anonAlb Feb. 18 at 3:41 PM
$SUGP we blowing up here soon! Load load load 🚨🚨🚨🚀🚀🚀🚀🚀 $XTLB $SENS
0 · Reply
batmantradingzz
batmantradingzz Feb. 18 at 3:37 PM
$SUGP if u missed $SNSE $XTLB SUGP be early Potential next 500k floater to go
0 · Reply
CandleVoyager
CandleVoyager Feb. 18 at 10:00 AM
$XTLB Energy infrastructure exposure where contract stability underpins valuation.
0 · Reply
Maggie_Pie
Maggie_Pie Feb. 17 at 11:52 PM
$XTLB I'm in for these cheapies. GL very
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 17 at 5:18 PM
$XTLB RSI: 47.69, MACD: 0.0089 Vol: 0.09, MA20: 0.93, MA50: 0.85 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
_EmproX
_EmproX Feb. 17 at 2:26 PM
$XTLB $LSE $FGNX $ENLT ****
0 · Reply
Kesiya
Kesiya Feb. 17 at 1:59 PM
$XTLB Buying zone.
1 · Reply
StonkTamer
StonkTamer Feb. 17 at 9:14 AM
$XTLB Obscure micro-cap; minimal coverage
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:13 PM
$XTLB RSI: 67.02, MACD: 0.0574 Vol: 0.18, MA20: 0.81, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ABnb15
ABnb15 Jan. 22 at 5:39 PM
$XTLB
0 · Reply
Hadaddy1211
Hadaddy1211 Jan. 21 at 5:26 PM
$XTLB why’s nobody talking about this!? Went up almost 60% in a week
1 · Reply
RonBoy3
RonBoy3 Jan. 15 at 1:25 PM
$XTLB See you shorts at the EOD…hey. hey, hey!
0 · Reply
RonBoy3
RonBoy3 Jan. 15 at 12:07 PM
$XTLB Nice way to start the day…!
0 · Reply
Zackpedia
Zackpedia Jan. 14 at 8:02 PM
$XTLB Down to .8
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:18 PM
$XTLB https://youtu.be/ygBN8MilTyc
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:10 PM
$XTLB https://youtu.be/z_sivgG6Cyg
0 · Reply
Fufat
Fufat Jan. 14 at 3:59 PM
$XTLB Has anyone read their latest filings?
0 · Reply
DEXWireNews
DEXWireNews Jan. 14 at 3:46 PM
$XAIR dropped 21% at Wednesday's open, flirting with $1 support (RSI 65). Meanwhile, $XTLB to acquire 85% of XAIR's NeuroNOS, targeting innovative ASD therapeutics. Despite the dip, XAIR gets a "Strong Buy" with a $11 target from analysts. #stocks #biotech $XAIR
0 · Reply
Wildblitz
Wildblitz Jan. 14 at 2:13 PM
$XTLB Of course it tanks
0 · Reply
LowFloatArmy
LowFloatArmy Jan. 14 at 1:33 PM
$XTLB this is why I stopped holding stocks lol I got stuck here though so let’s goooo!!
0 · Reply
Roadto1mio
Roadto1mio Jan. 14 at 7:47 AM
$XAIR $XTLB
0 · Reply